[1]CurrentPatentAssignee:CSPCPHARMACEUTICALGROUPLIMITED-EP3632910,2020,A1
[1]Patent:EP3632910,2020,A1.Locationinpatent:Paragraph0264
[1]CurrentPatentAssignee:CSPCPHARMACEUTICALGROUPLIMITED-EP3632910,2020,A1Locationinpatent:Paragraph0265
23062-51-3
28598-81-4
6287-90-7
14273-90-6
29823-21-0
65868-63-5
133373-24-7 | Fmoc-N-Me-Tyr(tBu)-OH | AA0014O9 | MFCD02684471
1214361-39-3 | 2-Amino-3-Bromo-6-trifluoromethylpyridine | AA0014U7 | MFCD13185328
1215205-80-3 | 2'-Hydroxy-3'-methoxybiphenyl-3-carboxylic acid | AA00152N | MFCD15143532
1215916-40-7 | Methyl 5-bromo-2-methylpyridine-3-carboxylate | AA0015A5 | MFCD13705366
1217500-61-2 | Oxindole-6-boronic acid | AA0015OI | MFCD12913936
1217792-29-4 | (R)-2-(3-Phenylpropyl)pyrrolidine-2-carboxylic acid hydrochloride | AA0015WD | MFCD06659212
1218790-63-6 | 2-Propoxy-5-(trifluoromethyl)pyridine-3-boronic acid | AA00166P | MFCD15143467
1219454-89-3 | 2-(Difluoromethylsulfonyl)pyridine | AA0016CO | MFCD17010193
1220630-83-0 | 3-Amino-4-(trifluoromethyl)benzonitrile | AA0016M8 | MFCD18072580
1222781-70-5 | (4-Methoxybenzyl)(1-naphthylmethyl)amine hydrochloride | AA0016Y2 | MFCD20921521